| #33 |
Kenneth E. Wohltmann |
Rohm And Haas |
1 |
| #33 |
Stephen D. Thompson |
Rohm And Haas |
1 |
| #33 |
Steven B. Liebers |
Diversified Products |
1 |
| #33 |
Xiang Qian Liu |
— |
1 |
| #33 |
Alan L. Boyd |
Certainteed |
1 |
| #33 |
Dave Shell |
Iqvia |
1 |
| #33 |
Joelle Lorraine Burgess |
Glaxosmithkline |
1 |
| #33 |
John James Dougherty |
GE |
1 |
| #33 |
John Hayes |
Rohm And Haas |
1 |
| #33 |
Jerry L. Adams |
Smithkline Beecham Limited |
1 |
| #33 |
Eric Steven Manas |
Pfizer |
1 |
| #33 |
Lawrence H. Judovits |
Arkema |
1 |
| #33 |
Ralph A. Rivero |
Merck |
1 |
| #33 |
Robert R. Singhaus, Jr. |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #33 |
Steven William Butcher |
Rb Distribution |
1 |
| #33 |
Reetam Chakrabarti |
Rohm And Haas |
1 |
| #33 |
Kimberly Katherine Marcus |
Fmc |
1 |
| #33 |
Kenneth Wiggall |
Glaxosmithkline |
1 |
| #33 |
Adam Kenneth Charnley |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #33 |
Murali K. Vuppala |
Johnson & Johnson |
1 |
| #33 |
Brittney Gurda |
University Of North Carolina At Chapel Hill |
1 |
| #33 |
Himal Ray |
Rohm And Haas |
1 |
| #33 |
Sean Patrick Hoelzle |
Sprint Communications |
1 |
| #33 |
Mark A. Seefeld |
Affinium Pharmaceuticals |
1 |
| #33 |
Junya Qu |
Glaxosmithkline |
1 |
| #33 |
Karen Anderson Evans |
Cancer Research Technology Limited |
1 |
| #33 |
Ryan Michael Fox |
Glaxosmithkline |
1 |
| #33 |
Pamela A. Haile |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #33 |
Christopher W. Scharff |
X-Nav Technologies |
1 |
| #33 |
Xiaoyang Dong |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #33 |
Joseph E. Pero |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #33 |
Rick R. Lesniewski |
Abb Vie |
1 |
| #33 |
Kathleen A. Auld |
Rohm And Haas |
1 |
| #33 |
Diamond Dyer |
Dow Global Technologies |
1 |
| #33 |
William Henry Miller |
Smithkline Beecham Limited |
1 |
| #33 |
Kelcie Zegalia |
Dow Global Technologies |
1 |
| #33 |
Emile P. Lemay, III |
Diversified Products |
1 |
| #33 |
Rosanna Tedesco |
Glaxosmithkline |
1 |
| #33 |
Antony N. Shaw |
Glaxosmithkline |
1 |
| #33 |
Taraka Sai Pavan Grandhi |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
1 |
| #33 |
Gren Z. Wang |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #33 |
Joshi M. Ramanjulu |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #33 |
Bruce E. Tomczuk |
3-Dimensional Pharmaceuticals |
1 |
| #33 |
David F. Brumbaugh |
Arris Enterprises |
1 |
| #33 |
Mark Tornetta |
Johnson & Johnson |
1 |
| #33 |
Katherine L. Widdowson |
Smithkline Beecham Limited |
1 |
| #33 |
Patrick M. Eidam |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #33 |
Steven David Knight |
Cytokinetics |
1 |